TECHNOL HEALTH CARE 润色咨询

TECHNOLOGY AND HEALTH CARE

出版年份：暂无数据 年文章数：1244 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：8.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1235473, encodeId=52c212354e3d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：网络药理学;分析对接<br>经验分享：我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45088253665, createdName=ms7000001058934714, createdTime=Fri Jul 29 14:56:03 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218197, encodeId=b056121819edf, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：投一次就中了，也没有返修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16c05095435, createdName=145e1191m98(暂无昵称), createdTime=Mon May 09 15:10:09 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511510, encodeId=6062511510f1, content=没有相关经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5d78558, createdName=ddhiyeah, createdTime=Tue Apr 28 13:41:00 CST 2015, time=2015-04-28, status=1, ipAttribution=)]
    2022-07-29 ms7000001058934714

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：网络药理学;分析对接
    经验分享：我

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1235473, encodeId=52c212354e3d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：网络药理学;分析对接<br>经验分享：我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45088253665, createdName=ms7000001058934714, createdTime=Fri Jul 29 14:56:03 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218197, encodeId=b056121819edf, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：投一次就中了，也没有返修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16c05095435, createdName=145e1191m98(暂无昵称), createdTime=Mon May 09 15:10:09 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511510, encodeId=6062511510f1, content=没有相关经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5d78558, createdName=ddhiyeah, createdTime=Tue Apr 28 13:41:00 CST 2015, time=2015-04-28, status=1, ipAttribution=)]
    2022-05-09 145e1191m98(暂无昵称)

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：投一次就中了，也没有返修

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1235473, encodeId=52c212354e3d3, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：网络药理学;分析对接<br>经验分享：我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45088253665, createdName=ms7000001058934714, createdTime=Fri Jul 29 14:56:03 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218197, encodeId=b056121819edf, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：投一次就中了，也没有返修, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16c05095435, createdName=145e1191m98(暂无昵称), createdTime=Mon May 09 15:10:09 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511510, encodeId=6062511510f1, content=没有相关经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5d78558, createdName=ddhiyeah, createdTime=Tue Apr 28 13:41:00 CST 2015, time=2015-04-28, status=1, ipAttribution=)]
    2015-04-28 ddhiyeah

    没有相关经验

    0

共46条页码: 2/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分